Literature DB >> 12571077

Hyperleptinemia and reduced TNF-alpha secretion cause resistance of db/db mice to endotoxin.

Abram M Madiehe1, Tiffany D Mitchell, Ruth B S Harris.   

Abstract

Leptin deficiency in ob/ob mice increases susceptibility to endotoxic shock, whereas leptin pretreatment protects them against LPS-induced lethality. Lack of the long-form leptin receptor (Ob-Rb) in db/db mice causes resistance. We tested the effects of LPS in C57BL/6J db(3J)/db(3J) (BL/3J) mice, which express only the circulating leptin receptors, compared with C57BL/6J db/db (BL/6J) mice, which express all short-form and circulating isoforms of the leptin receptor. Intraperitoneal injections of LPS significantly decreased rectal temperature and increased leptin, corticosterone, and free TNF-alpha in fed and fasted BL/3J and BL/6J mice. TNF-alpha was increased three- and fourfold in BL/3J and BL/6J, respectively. LPS (100 microg) caused 50% mortality of fasted BL/6J mice but caused no mortality in fasted BL/3J mice. Pretreatment of fasted BL/3J mice with 30 microg leptin prevented the drop in rectal temperature, blunted the increase in corticosterone, but had no effect on TNF-alpha induced by 100 microg LPS. Taken together, these data provide evidence that fasted BL/3J mice are more resistant than BL/6J mice to LPS toxicity, presumably due to the absence of leptin receptors in BL/3J mice. This resistance may be due to high levels of free leptin cross-reacting with other cytokine receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12571077     DOI: 10.1152/ajpregu.00610.2002

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  12 in total

Review 1.  Immunosenescence of ageing.

Authors:  A L Gruver; L L Hudson; G D Sempowski
Journal:  J Pathol       Date:  2007-01       Impact factor: 7.996

2.  Leptin selectively augments thymopoiesis in leptin deficiency and lipopolysaccharide-induced thymic atrophy.

Authors:  Ryan W Hick; Amanda L Gruver; Melissa S Ventevogel; Barton F Haynes; Gregory D Sempowski
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

3.  Leptin exacerbates sepsis-mediated morbidity and mortality.

Authors:  Nathan I Shapiro; Eliyahu V Khankin; Matijs Van Meurs; Shou-Ching Shih; Shulin Lu; Midori Yano; Pedro R Castro; Eleftheria Maratos-Flier; Samir M Parikh; S Ananth Karumanchi; Kiichiro Yano
Journal:  J Immunol       Date:  2010-06-02       Impact factor: 5.422

4.  Effect of intestinal ischemia-reperfusion injury on protein levels of leptin and orexin-A in peripheral blood and central secretory tissues.

Authors:  Ji Lin; Guang-Tao Yan; Xiu-Hua Hao; Lu-Huan Wang; Kai Zhang; Hui Xue
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

5.  Sepsis-induced inflammation is exacerbated in an animal model of type 2 diabetes.

Authors:  Asha Jacob; Marissa L Steinberg; Juntao Yang; Weifeng Dong; Youxin Ji; Ping Wang
Journal:  Int J Clin Exp Med       Date:  2008-01-10

6.  Effect of intestinal ischemia/reperfusion injury on leptin and orexin-A levels.

Authors:  Ji Lin; Guangtao Yan; Xiaoning Gao; Jie Liao; Xiuhua Hao; Kai Zhang
Journal:  Front Med China       Date:  2007-02

Review 7.  Emerging role of leptin in rheumatoid arthritis.

Authors:  G Tian; J-N Liang; Z-Y Wang; D Zhou
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

8.  Factors that may impact on immunosenescence: an appraisal.

Authors:  Joseph Ongrádi; Valéria Kövesdi
Journal:  Immun Ageing       Date:  2010-06-14       Impact factor: 6.400

9.  Leptin receptor polymorphisms and lung function decline in COPD.

Authors:  N N Hansel; L Gao; N M Rafaels; R A Mathias; E R Neptune; C Tankersley; A V Grant; J Connett; T H Beaty; R A Wise; K C Barnes
Journal:  Eur Respir J       Date:  2009-02-05       Impact factor: 16.671

10.  Role of leptin and melanocortin signaling in uremia-associated cachexia.

Authors:  Wai Cheung; Pin X Yu; Brian M Little; Roger D Cone; Daniel L Marks; Robert H Mak
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.